Quick Answer
The 1.7mg dose is one step below maximum and brings the strongest appetite suppression many patients have experienced. The jump from 1.0mg to 1.7mg is the largest single increase in the titration protocol (0.7mg), which means the adjustment period can be more noticeable. Expect 3 to 7 days of renewed GI symptoms that resolve as the body adapts. Constipation intensifies at this dose, and some patients notice fatigue during the first week. Patients who plateau at lower doses often see weight loss restart at 1.7mg. The trade-off between stronger effects and stronger side effects is the central question at this dose level.
Medical Disclaimer: This article is for informational purposes only. Dose increases should always be guided by your healthcare provider based on your clinical response and tolerance.
The Biggest Jump in the Protocol
The Wegovy titration goes: 0.25 to 0.5 (+0.25mg), 0.5 to 1.0 (+0.5mg), 1.0 to 1.7 (+0.7mg), 1.7 to 2.4 (+0.7mg). The step from 1.0 to 1.7 is a 70% increase in dose, the largest proportional jump in the lower part of the protocol. This matters because the body's adaptation to each dose level is relative. A 70% increase requires more adjustment than the 100% increase from 0.25 to 0.5 (which was from a subtherapeutic level) because you are now increasing from a dose where significant GLP-1 receptor activation is already present.
View data table
| Category | Treatment Progress (%) | Detail |
|---|---|---|
| Week 1-2 | 25 | Appetite reduction begins |
| Month 1 | 45 | Nausea subsides, energy improves |
| Month 3 | 70 | Visible weight loss (~5-8%) |
| Month 6 | 85 | Significant results (~10-15%) |
| Month 12 | 95 | Full therapeutic benefit |
FormBlends prepares patients for this transition by setting expectations clearly: the adjustment will be noticeable, it will resolve, and the temporary discomfort is the price of reaching a more effective dose. Patients who have successfully navigated previous dose increases have the skills and experience to manage this one.
Who Needs the 1.7mg Dose
Not everyone needs to go above 1.0mg. Patients who reach 1.7mg typically fall into three categories. First, those following the standard Wegovy protocol toward the 2.4mg target dose. Second, patients who plateaued at 1.0mg after an initial period of weight loss. Third, patients with a large amount of weight to lose who need stronger pharmacological support to reach their goals.
Get provider-reviewed GLP-1 therapy
Side effects are manageable with the right support. A licensed provider can adjust your dose when you need it.
Start Free Assessment →FormBlends evaluates the need for dose escalation using objective criteria: has weight loss stalled for 4 to 6 weeks? Is the patient adherent to dietary and activity recommendations? Has a review confirmed there are no other factors (medication interactions, thyroid issues, fluid retention) explaining the plateau? If the answer is yes to these questions, increasing to 1.7mg is appropriate. For guidance on recognizing plateaus, see our article on whether 1.7mg is worth it.
Side Effect Profile at 1.7mg
| Side Effect | At 1.0mg | At 1.7mg | Notes |
|---|---|---|---|
| Nausea (during adjustment) | 10 to 15% | 25 to 35% | Returns briefly during dose transition |
| Constipation | 20 to 25% | 25 to 30% | More persistent, may need stronger management |
| Appetite suppression | 60 to 70% | 75 to 85% | Stronger, more consistent suppression |
| Fatigue | 10 to 15% | 15 to 20% | Often caloric-deficit related |
| Bloating | 8 to 12% | 12 to 18% | Increased with further gastric emptying delay |
The overall side effect profile at 1.7mg is an intensification of what patients experienced at 1.0mg rather than a qualitatively different experience. Patients who managed well at 1.0mg generally manage well at 1.7mg after the initial adjustment period.
The Adjustment Period
Expect 3 to 7 days of renewed side effects after your first 1.7mg injection. The pattern mirrors previous dose increases: nausea peaking around days 3 to 5, appetite suppression intensifying, and GI discomfort before adaptation occurs. By the second injection at this dose, most patients report significant improvement.
The strategies that worked at previous dose increases work here too: smaller meals, reduced fat, ginger tea, staying hydrated, and timing the increase for when you have schedule flexibility. FormBlends provides the same dose-increase support at 1.7mg as at every other step, including pre-increase preparation guidance and post-increase check-ins.
Patients who had smooth transitions at 0.5mg and 1.0mg often worry unnecessarily about 1.7mg. The accumulated tolerance from months of semaglutide use means your body is increasingly efficient at adapting to dose changes. For detailed transition strategies, see our dose increase article.
Constipation Intensifies
If constipation was manageable at 1.0mg, it may need more aggressive management at 1.7mg. The further slowing of GI motility means longer transit time and harder stools. Patients who were managing with fiber alone at 1.0mg may need to add magnesium citrate or polyethylene glycol at 1.7mg.
FormBlends proactively adjusts the constipation management plan when increasing to 1.7mg. We recommend increasing fiber to 30 to 35 grams daily, adding magnesium citrate (400mg at bedtime) if not already using it, and increasing water intake to 72 to 80 ounces daily. These adjustments often prevent constipation from becoming a significant issue at the higher dose. For the full constipation protocol, see our constipation article.
Community Reports: The 1.0 to 1.7 Jump
r/Semaglutide: "Just went from 1.0 to 1.7 and the nausea is real"
34 upvotes, 28 comments
A patient described the 1.0 to 1.7 jump as the most noticeable dose increase in their entire titration. They experienced 4 days of moderate nausea, significantly reduced appetite (barely eating 800 calories on day 3), and fatigue. By day 7, symptoms had improved substantially. Commenters shared similar experiences and emphasized that this dose increase is where the medication really demonstrates its full potential.
Top comment: "The 1.0 to 1.7 jump hit me harder than any other increase. But it also restarted my weight loss after a 6-week plateau."
r/Semaglutide: "Staying at 1.7, no need for 2.4 for me"
41 upvotes, 33 comments
A patient who had been at 1.7mg for 5 months shared that they decided not to increase to the maximum dose. Their reasoning: steady weight loss of 1 to 1.5 pounds per week, manageable side effects, and concern that 2.4mg would bring stronger constipation and further reduce their already limited appetite. The thread generated debate about whether reaching 2.4mg is necessary for everyone.
Top comment: "If 1.7 is working, why go higher? The goal is weight loss, not maximum dose."
Clinical gap: The Wegovy titration protocol does not account for individual response variability. A standardized approach that assesses response at each dose level before increasing (rather than automatic escalation at fixed intervals) would better serve patients. Biomarkers that predict optimal individual dose remain unidentified.
Intermediate Dosing Options
Some providers use intermediate steps between 1.0mg and 1.7mg, particularly for patients who had difficult adjustments at previous increases. A step to 1.25mg or 1.5mg before reaching 1.7mg can smooth the transition. This requires dose-adjustable pens or compounded formulations, both of which FormBlends can provide.
The clinical rationale is straightforward: smaller dose increments produce smaller spikes in side effects. The trade-off is a longer time to reach the target dose. For patients with no urgency, this gentler approach reduces the risk of severe side effects that might lead to treatment discontinuation.
Frequently Asked Questions
Why is the 1.0 to 1.7mg jump the biggest increase?
At 0.7mg, it is the largest absolute increase in the protocol. This means proportionally greater GLP-1 receptor activation and a more noticeable adjustment period.
Who needs the 1.7mg dose?
Patients who plateaued at 1.0mg, those following the standard protocol toward 2.4mg, and patients with significant weight left to lose who need stronger pharmacological support.
Are side effects worse at 1.7mg?
Some patients report stronger GI effects during the first 1 to 2 weeks. Constipation may worsen and nausea briefly returns. The adjustment period is typically shorter than anticipated.
How long does adjustment to 1.7mg take?
Most patients adjust within 1 to 2 weeks. The first injection may bring 3 to 7 days of increased side effects, resolving by the second or third injection at this dose.
Can I go from 1.0 to 1.7 more gradually?
Some providers use intermediate steps at 1.25mg or 1.5mg. This is off-protocol but reduces side effect severity during the transition.
Is 1.7mg the penultimate dose?
Yes. The only remaining increase is to 2.4mg (the maximum). Patients who do well at 1.7mg may stay or proceed to the maximum based on their response and goals.
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →